Document Detail


Hsp90 Prevents Interaction between CHIP and HERG Proteins to Facilitate Maturation of Wild-type and Mutant HERG Proteins.
MedLine Citation:
PMID:  23963841     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
AIMS: We examined the role of Hsp90 in expression and maturation of wild-type and mutant HERG proteins by using Hsp90 inhibitors, geldanamycine (GA) and radicicol, and Hsp90 overexpression.Methods and ResultsThe proteins were expressed in HEK293 cells or collected from HL-1 mouse cardiomyocytes, and analyzed by Western blotting, immunoprecipitation, immunofluorescence and whole-cell patch-clamp techniques. GA and radicicol suppressed maturation of HERG-FLAG proteins and increased their immature forms. Co-expression of Hsp90 counteracted the effects of Hsp90 inhibitors and suppressed ubiquitination of HERG proteins. Overexpressed Hsp90 also inhibited the binding of endogenous C-terminus of Hsp70-interacting protein (CHIP) to HERG-FLAG proteins. Hsp90-induced increase of functional HERG proteins was verified by their increased expression on the cell surface and enhanced HERG channel currents. CHIP overexpression decreased both mature and immature forms of HERG-FLAG proteins in cells treated with GA. Hsp90 facilitated maturation of endogenous ERG proteins, whereas CHIP decreased both forms of ERG proteins in HL-1 cells. Mutant HERG proteins harboring disease-causing missense mutations were mainly in the immature form and had a higher binding capacity to CHIP than the wild-type; Hsp90 overexpression suppressed this association. Overexpressed Hsp90 increased the mature form of HERG(1122fs/147) proteins, reduced its ubiquitinated form, increased its immunoreactivity in the endoplasmic reticulum and on the plasma membrane, and increased the mutant-mediated membrane current. CHIP overexpression decreased the immature form of HERG(1122fs/147) proteins.
CONCLUSION: Enhancement of HERG protein expression through Hsp90 inhibition of CHIP binding might be a novel therapeutic strategy for LQT2 caused by trafficking abnormalities of HERG proteins.
Authors:
Chisato Iwai; Peili Li; Yasutaka Kurata; Yoshiko Hoshikawa; Kumi Morikawa; Nani Maharani; Katsumi Higaki; Tetsuro Sasano; Tomomi Notsu; Yuko Ishido; Junichiro Miake; Yasutaka Yamamoto; Yasuaki Shirayoshi; Haruaki Ninomiya; Akira Nakai; Shigeo Murata; Akio Yoshida; Kazuhiro Yamamoto; Masayasu Hiraoka; Ichiro Hisatome
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-8-20
Journal Detail:
Title:  Cardiovascular research     Volume:  -     ISSN:  1755-3245     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-8-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Regenerative Medicine and Therapeutics, Department of Genetic Medicine and Regenerative Therapeutics, Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science. Nishichou 86, Yonago 683, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosis.
Next Document:  NO-dependent CaMKII activation during ?-adrenergic stimulation of cardiac muscle.